Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Atb Cap Markets lowered their FY2024 earnings per share estimates for Jushi in a research note issued on Sunday, November 10th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of ($0.24) for the year, down from their prior estimate of ($0.20). The consensus estimate for Jushi's current full-year earnings is ($0.19) per share. Atb Cap Markets also issued estimates for Jushi's Q4 2024 earnings at ($0.06) EPS, FY2025 earnings at ($0.19) EPS, FY2026 earnings at ($0.15) EPS, FY2027 earnings at ($0.12) EPS and FY2028 earnings at ($0.11) EPS.
Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.04). Jushi had a negative return on equity of 5,529.11% and a negative net margin of 20.93%. The company had revenue of $61.61 million during the quarter, compared to analyst estimates of $65.53 million.
Separately, Ventum Cap Mkts raised shares of Jushi to a "hold" rating in a research report on Thursday, August 8th.
Get Our Latest Report on JUSHF
Jushi Trading Up 16.6 %
OTCMKTS JUSHF traded up $0.06 on Wednesday, reaching $0.41. The company had a trading volume of 384,981 shares, compared to its average volume of 264,607. The stock's 50 day moving average is $0.50 and its 200-day moving average is $0.57. Jushi has a 52 week low of $0.22 and a 52 week high of $1.09.
About Jushi
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
Featured Articles
Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
